• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群与体重控制:体内的“体重观察者”?

Microbiota and body weight control: Weight watchers within?

机构信息

APC Microbiome Ireland, University College Cork, Cork, Ireland.

APC Microbiome Ireland, University College Cork, Cork, Ireland; Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.

出版信息

Mol Metab. 2022 Mar;57:101427. doi: 10.1016/j.molmet.2021.101427. Epub 2021 Dec 29.

DOI:10.1016/j.molmet.2021.101427
PMID:34973469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8829807/
Abstract

BACKGROUND

Despite several decades of research, managing body weight remains an unsolved clinical problem. Health problems associated with dysregulated body weight, such as obesity and cachexia, exhibit several gut microbiota alterations. There is an increased interest in utilising the gut microbiota for body weight control, as it responds to intervention and plays an important role in energy extraction from food, as well as biotransformation of nutrients.

SCOPE OF THE REVIEW

This review provides an overview of the role of the gut microbiota in the physiological and metabolic alterations observed in two body weight dysregulation-related disorders, namely obesity and cachexia. Second, we assess the available evidence for different strategies, including caloric restriction, intermittent fasting, ketogenic diet, bariatric surgery, probiotics, prebiotics, synbiotics, high-fibre diet, and fermented foods - effects on body weight and gut microbiota composition. This approach was used to give insights into the possible link between body weight control and gut microbiota configuration.

MAJOR CONCLUSIONS

Despite extensive associations between body weight and gut microbiota composition, limited success could be achieved in the translation of microbiota-related interventions for body weight control in humans. Manipulation of the gut microbiota alone is insufficient to alter body weight and future research is needed with a combination of strategies to enhance the effects of lifestyle interventions.

摘要

背景

尽管经过了几十年的研究,体重管理仍然是一个尚未解决的临床问题。与体重失调相关的健康问题,如肥胖和恶病质,表现出几种肠道微生物群的改变。人们越来越有兴趣利用肠道微生物群来控制体重,因为它对干预有反应,并在从食物中提取能量以及营养物质的生物转化方面发挥重要作用。

综述范围

本文综述了肠道微生物群在两种与体重失调相关的疾病(肥胖和恶病质)中观察到的生理和代谢改变中的作用。其次,我们评估了不同策略的现有证据,包括热量限制、间歇性禁食、生酮饮食、减肥手术、益生菌、益生元、合生元、高纤维饮食和发酵食品-对体重和肠道微生物群组成的影响。这种方法用于深入了解体重控制和肠道微生物群结构之间可能存在的联系。

主要结论

尽管体重与肠道微生物群组成之间存在广泛的关联,但在将与微生物群相关的干预措施转化为人类体重控制方面,取得的成功有限。单独操纵肠道微生物群不足以改变体重,需要结合多种策略进行未来研究,以增强生活方式干预的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/7164c6c41832/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/003ffc40ad55/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/025895244eda/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/8a3853054e54/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/7164c6c41832/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/003ffc40ad55/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/025895244eda/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/8a3853054e54/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8829807/7164c6c41832/gr4.jpg

相似文献

1
Microbiota and body weight control: Weight watchers within?肠道菌群与体重控制:体内的“体重观察者”?
Mol Metab. 2022 Mar;57:101427. doi: 10.1016/j.molmet.2021.101427. Epub 2021 Dec 29.
2
GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.肠道微生物群、益生元、益生菌和合生菌在肥胖和糖尿病管理中的应用:随机对照试验综述。
Endocr Pract. 2016 Oct;22(10):1224-1234. doi: 10.4158/EP151157.RA. Epub 2016 Jul 13.
3
The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.益生菌、益生元和合生菌对肥胖宿主的生化、临床和免疫标志物以及肠道微生物群的影响。
Crit Rev Food Sci Nutr. 2021;61(2):337-355. doi: 10.1080/10408398.2020.1733483. Epub 2020 Mar 10.
4
Does gut microbiota affect the success of weight loss? Evidence and speculation.肠道微生物群会影响减肥的成效吗?证据与推测。
Nutrition. 2023 Dec;116:112111. doi: 10.1016/j.nut.2023.112111. Epub 2023 May 31.
5
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
6
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.益生菌、益生元、合生元和后生元对靶向肠道微生物群的代谢性疾病的影响和作用机制:一种叙述性综述。
Nutrients. 2021 Sep 15;13(9):3211. doi: 10.3390/nu13093211.
7
Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.针对肠道微生物群治疗多种疾病的不同策略:一种可持续的方法。
Infect Disord Drug Targets. 2024;24(5):e160124225675. doi: 10.2174/0118715265267536231121095634.
8
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
9
Understanding the gut microbiota in cancer cachexia.了解癌症恶病质中的肠道微生物组。
Curr Opin Clin Nutr Metab Care. 2023 Sep 1;26(5):482-489. doi: 10.1097/MCO.0000000000000957. Epub 2023 Jun 22.
10
Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.益生菌、益生元、合生菌、后生元与肥胖:当前的证据、争议和观点。
Curr Obes Rep. 2020 Sep;9(3):179-192. doi: 10.1007/s13679-020-00379-w.

引用本文的文献

1
The Role of Gut Microbiota in the Development and Treatment of Obesity and Overweight: A Literature Review.肠道微生物群在肥胖和超重的发生发展及治疗中的作用:文献综述
J Clin Med. 2025 Jul 11;14(14):4933. doi: 10.3390/jcm14144933.
2
Microbiota-gut-brain axis in binge-eating disorder: Towards microbiome-based therapies.暴饮暴食症中的微生物群-肠道-脑轴:迈向基于微生物组的疗法。
Neurosci Appl. 2024 Aug 29;3:104088. doi: 10.1016/j.nsa.2024.104088. eCollection 2024.
3
Microbiome: A Key Regulator of Body-Brain Interactions.微生物群:身体与大脑相互作用的关键调节因子。

本文引用的文献

1
spp. promotes branched-chain amino acid catabolism in brown fat and inhibits obesity.某物种促进棕色脂肪中的支链氨基酸分解代谢并抑制肥胖。
iScience. 2021 Oct 24;24(11):103342. doi: 10.1016/j.isci.2021.103342. eCollection 2021 Nov 19.
2
Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols.动物粪便移植(GRAFT)研究报告指南:对小鼠移植方案系统评价的建议。
Gut Microbes. 2021 Jan-Dec;13(1):1979878. doi: 10.1080/19490976.2021.1979878.
3
Chains of evidence from correlations to causal molecules in microbiome-linked diseases.
Adv Exp Med Biol. 2025;1477:139-203. doi: 10.1007/978-3-031-89525-8_6.
4
Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment.微生物群、潜在治疗剂:肥胖治疗的新参与者
J Microbiol Biotechnol. 2025 Apr 24;35:e2501024. doi: 10.4014/jmb.2501.01024.
5
Celiac Disease, Gluten-Free Diet, and Eating Disorders: From Bench to Bedside.乳糜泻、无麸质饮食与饮食失调:从实验台到病床边
Foods. 2024 Dec 31;14(1):74. doi: 10.3390/foods14010074.
6
A Role for the Microbiota-Gut-Brain Axis in Avoidant/Restrictive Food Intake Disorder: A New Conceptual Model.微生物群-肠-脑轴在回避/限制性食物摄入障碍中的作用:一种新的概念模型。
Int J Eat Disord. 2024 Dec;57(12):2321-2328. doi: 10.1002/eat.24326. Epub 2024 Nov 14.
7
Gut physiology meets microbiome science.肠道生理学与微生物组科学相遇。
Gut Microbiome (Camb). 2022 Dec 12;4:e1. doi: 10.1017/gmb.2022.10. eCollection 2023.
8
Feeding gut microbes to nourish the brain: unravelling the diet-microbiota-gut-brain axis.通过喂养肠道微生物来滋养大脑:揭示饮食-微生物群-肠道-大脑轴。
Nat Metab. 2024 Aug;6(8):1454-1478. doi: 10.1038/s42255-024-01108-6. Epub 2024 Aug 22.
9
The Role of Adipocytes Recruited as Part of Tumor Microenvironment in Promoting Colorectal Cancer Metastases.脂肪细胞作为肿瘤微环境的一部分在促进结直肠癌转移中的作用。
Int J Mol Sci. 2024 Jul 30;25(15):8352. doi: 10.3390/ijms25158352.
10
Human Gut Microbiome Before and After Bariatric Surgery in Obese Patients with and Without Type 2 Diabetes.肥胖伴或不伴 2 型糖尿病患者行减重手术后的肠道微生物组变化。
Obes Surg. 2024 Aug;34(8):2835-2843. doi: 10.1007/s11695-024-07364-5. Epub 2024 Jun 24.
从相关性到微生物组关联疾病中的因果分子的证据链。
Nat Chem Biol. 2021 Oct;17(10):1046-1056. doi: 10.1038/s41589-021-00861-z. Epub 2021 Sep 22.
4
Excess Body Weight and Pancreatic Disease.超重与胰腺疾病
Visc Med. 2021 Aug;37(4):281-286. doi: 10.1159/000517147. Epub 2021 Jul 9.
5
Baseline Gut Metagenomic Functional Gene Signature Associated with Variable Weight Loss Responses following a Healthy Lifestyle Intervention in Humans.与人类健康生活方式干预后体重减轻反应差异相关的基线肠道宏基因组功能基因特征
mSystems. 2021 Oct 26;6(5):e0096421. doi: 10.1128/mSystems.00964-21. Epub 2021 Sep 14.
6
The promise of the gut microbiome as part of individualized treatment strategies.肠道微生物组作为个体化治疗策略的一部分的前景。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):7-25. doi: 10.1038/s41575-021-00499-1. Epub 2021 Aug 27.
7
Long-Term Effects of Bariatric Surgery on Gut Microbiota Composition and Faecal Metabolome Related to Obesity Remission.减重手术对肠道微生物组成和与肥胖缓解相关的粪便代谢组的长期影响。
Nutrients. 2021 Jul 23;13(8):2519. doi: 10.3390/nu13082519.
8
Gut microbes participate in food preference alterations during obesity.肠道微生物参与肥胖过程中的食物偏好改变。
Gut Microbes. 2021 Jan-Dec;13(1):1959242. doi: 10.1080/19490976.2021.1959242.
9
Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity.新生期接触野生来源微生物组可保护小鼠免受饮食诱导的肥胖。
Nat Metab. 2021 Aug;3(8):1042-1057. doi: 10.1038/s42255-021-00439-y. Epub 2021 Aug 20.
10
Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials.益生菌对超重和肥胖个体身体肥胖及心血管风险标志物的影响:一项随机对照试验的系统评价和荟萃分析
Clin Nutr. 2021 Aug;40(8):4915-4931. doi: 10.1016/j.clnu.2021.06.023. Epub 2021 Jul 3.